Physician profile
Mark W Featherston
NPI 1073572533
$1,044.30
in general payments reported to CMS, 2019-2025
10 companies · $72.82 in 2025
The $72.82 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.41 · 2020: $51.50 · 2021: $100 · 2022: $53.00 · 2023: $623 · 2024: $72.95 · 2025: $72.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $768.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $768.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenacare Global, LLC | $362.40 | 2023 | |
| Tactile Systems Technology INC | $231.43 | 2023-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Boston Scientific Corporation | $138.15 | 2021-2023 | Varithena Administration Pack |
| Medtronic, INC. | $107.50 | 2021-2022 | |
| Medtronic Vascular, INC. | $93.41 | 2019-2020 | |
| Organogenesis INC. | $54.27 | 2023-2024 | Apligraf, Puraply |
| Biocompatibles, INC. | $17.13 | 2019 | |
| Cashflow Solutions, LLC | $14.14 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Bard Peripheral Vascular, INC. | $13.50 | 2022 | |
| Ge Healthcare | $12.37 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Featherston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.